Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum MedMira Inc V.MIR

Alternate Symbol(s):  MMIRF

MedMira Inc. is a Canada-based developer and manufacturer of Rapid Vertical Flow (RVF) diagnostics. The Company's tests provide hospitals, labs, clinics and individuals with instant disease diagnosis, such as human immunodeficiency virus (HIV), syphilis, hepatitis, and SARS-CoV-2, in three steps. The Company is engaged in the business of research, development and manufacturing of rapid... see more

TSXV:MIR - Post Discussion

MedMira Inc > MEDMIRA TO PAY DIVIDEND 2025
View:
Post by goldyhawk on Feb 23, 2024 12:47pm

MEDMIRA TO PAY DIVIDEND 2025

A rumour is that management told this to shareholders at AGM if they are still running the business 
LOL
Comment by Petey78 on Feb 24, 2024 10:45am
HAHAHAHA... We will see dividends when the leafs win the cup. 
Comment by waverleywharf on Feb 25, 2024 4:28pm
No one has ever seen it on colour TV. That being the case there is always this year (or next). Come on Austin and MedMira. One can only hope. Gettin' real old waiting on either.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities